RiaSTAP 1 MG Injection
- RxCUI
- 831509
- RxNorm name
- RiaSTAP 1 MG Injection
- Display name
- RiaSTAP 1 MG Injection
- Full name
- RiaSTAP 1 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125317 | Riastap | Fibrinogen Concentrate (Human) | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RiaSTAP | FIBRINOGEN HUMAN | CSL Behring GmbH | 903dc8d0-39da-462c-9dac-004e0c7a26cc | 2025-12-29 | Warnings, Adverse reactions | 831509 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 903dc8d0-39da-462c-9dac-004e0c7a26cc | RiaSTAP 1 MG Injection [PSN] · fibrinogen, human 1 MG Injection [RiaSTAP] [SBD] · RiaSTAP 1 MG Injection [SY] | 3 | 19 | These highlights do not include all the information needed to use RIASTAP ® safely and effectively. See full prescribing information for RIASTAP. RIASTAP, Fibrinogen Concentrate (Human) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2009 | 20251229 |